4//SEC Filing
Butler John P. 4
Accession 0001562180-23-002201
CIK 0001517022other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 8:01 AM ET
Size
11.4 KB
Accession
0001562180-23-002201
Insider Transaction Report
Form 4
Butler John P.
DirectorCEO and President
Transactions
- Sale
Common Stock
2023-03-01$0.88/sh−38,259$33,572→ 1,622,481 total - Sale
Common Stock
2023-03-01$0.88/sh−47,239$41,452→ 1,575,242 total - Sale
Common Stock
2023-03-01$0.88/sh−6,370$5,590→ 1,568,872 total
Holdings
- 100,000(indirect: Held By John Butler GRAT November 2019)
Common Stock
- 59,928(indirect: Held by John Butler 2019 GRAT)
Common Stock
- 100,000(indirect: Held By Dorothy Butler GRAT November 2019)
Common Stock
- 59,928(indirect: Held by Dorothy Butler 2019 GRAT)
Common Stock
Footnotes (3)
- [F1]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2020.
- [F2]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2022.
- [F3]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the performance-based restricted stock units that were previously reported for the Reporting Person on a Form 4 filed on March 18, 2021.
Documents
Issuer
Akebia Therapeutics, Inc.
CIK 0001517022
Entity typeother
Related Parties
1- filerCIK 0001591467
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 8:01 AM ET
- Size
- 11.4 KB